Pharmacovigilance in India, Uganda and South Africa with Reference to WHO’s Minimum Requirements
Background Pharmacovigilance (PV) data are crucial for ensuring safety and effectiveness of medicines after drugs have been granted marketing approval. This paper describes the PV systems of India, Uganda and South Africa based on literature and Key Informant (KI) interviews and compares them with...
Main Authors: | Karen Maigetter, Allyson M. Pollock, Abhay Kadam, Kim Ward, Mitchell G. Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2015-05-01
|
Series: | International Journal of Health Policy and Management |
Subjects: | |
Online Access: | http://www.ijhpm.com/pdf_2985_b9e92f98bb5e8e7d59d17613ebd2c6ef.html |
Similar Items
-
Prospects of consumer-initiated adverse drug reaction reporting in cardiovascular pharmacovigilance
by: Vinu Wilson, et al.
Published: (2015-01-01) -
Studi pharmacovigilance obat di puskesmas X Yogyakarta
by: Mustika Muthaharah, et al.
Published: (2017-06-01) -
An update on the Pharmacovigilance Programme of India
by: Ratan J Lihite, et al.
Published: (2015-09-01) -
Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report
by: Shrestha S, et al.
Published: (2020-01-01) -
Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan
by: Akash Syed, et al.
Published: (2018-03-01)